Talaris Therapeutics Price on June 14, 2023
TALSDelisted Stock | USD 2.98 0.10 3.25% |
If you're considering investing in Talaris Stock, it is important to understand the factors that can impact its price. As of today, the current price of Talaris Therapeutics stands at 2.98, as last reported on the 21st of December, with the highest price reaching 3.08 and the lowest price hitting 2.98 during the day. We have found thirty technical indicators for Talaris Therapeutics, which you can use to evaluate the volatility of the company. Please validate Talaris Therapeutics' Risk Adjusted Performance of 0.1019, semi deviation of 3.08, and Coefficient Of Variation of 846.74 to confirm if the risk estimate we provide is consistent with the expected return of 0.0%.
Talaris Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
Talaris |
Sharpe Ratio = 0.0
Best Portfolio | Best Equity | |||
Good Returns | ||||
Average Returns | ||||
Small Returns | ||||
Cash | Small Risk | Average Risk | High Risk | Huge Risk |
TALS |
Based on monthly moving average Talaris Therapeutics is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Talaris Therapeutics by adding Talaris Therapeutics to a well-diversified portfolio.
Related Headline
Edgewise Therapeutics Headline on 14th of June 2023
Acquisition by Root Jonathan D of 22123 shares of Edgewise T... by Root Jonathan D
Filed transaction by Edgewise Therapeutics Inc director. Grant, award or other acquisition pursuant to Rule 16b-3(d)
Talaris Therapeutics Valuation on June 14, 2023
It is possible to determine the worth of Talaris Therapeutics on a given historical date. On June 14, 2023 Talaris was worth 2.57 at the beginning of the trading date compared to the closed value of 2.48. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Talaris Therapeutics stock. Still, in general, we apply an absolute valuation method to find Talaris Therapeutics' value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Talaris Therapeutics where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Talaris Therapeutics' related companies.
Open | High | Low | Close | Volume | |
2.66 | 2.66 | 2.52 | 2.54 | 160,200 | |
06/14/2023 | 2.57 | 2.59 | 2.42 | 2.48 | 164,000 |
2.48 | 2.50 | 2.43 | 2.48 | 109,500 |
Backtest Talaris Therapeutics | | | Talaris Therapeutics History | | | Talaris Therapeutics Valuation | Previous | Next |
Talaris Therapeutics Trading Date Momentum on June 14, 2023
On June 15 2023 Talaris Therapeutics was traded for 2.48 at the closing time. The top price for the day was 2.50 and the lowest listed price was 2.43 . The trading volume for the day was 109.5 K. The trading history from June 15, 2023 did not result in any price rise and fall. The trading price change against the current closing price is 23.79% . |
Talaris Therapeutics Fundamentals Correlations and Trends
By evaluating Talaris Therapeutics' financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Talaris Therapeutics' main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Talaris financial account trend analysis is a perfect complement when working with valuation or volatility modules.About Talaris Therapeutics Stock history
Talaris Therapeutics investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Talaris is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Talaris Therapeutics will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Talaris Therapeutics stock prices may prove useful in developing a viable investing in Talaris Therapeutics
Talaris Therapeutics, Inc. operates as a late-clinical stage cell therapy company in the United States. Talaris Therapeutics, Inc. was founded in 1988 and is headquartered in Louisville, Kentucky. Talaris Therapeutics operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 128 people.
Talaris Therapeutics Stock Technical Analysis
Talaris Therapeutics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, delisted stock market cycles, or different charting patterns.
Price Boundaries
Talaris Therapeutics Period Price Range
Low | December 21, 2024
| High |
0.00 | 0.00 |
Talaris Therapeutics cannot be verified against its exchange. Please verify the symbol is currently traded on NASDAQ Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
Talaris Therapeutics December 21, 2024 Market Strength
Market strength indicators help investors to evaluate how Talaris Therapeutics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Talaris Therapeutics shares will generate the highest return on investment. By undertsting and applying Talaris Therapeutics stock market strength indicators, traders can identify Talaris Therapeutics entry and exit signals to maximize returns
Talaris Therapeutics Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Talaris Therapeutics' price direction in advance. Along with the technical and fundamental analysis of Talaris Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Talaris to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
Risk Adjusted Performance | 0.1019 | |||
Jensen Alpha | 0.5506 | |||
Total Risk Alpha | 0.4243 | |||
Sortino Ratio | 0.1548 | |||
Treynor Ratio | 1.43 |
Cycle Indicators | ||
Math Operators | ||
Math Transform | ||
Momentum Indicators | ||
Overlap Studies | ||
Pattern Recognition | ||
Price Transform | ||
Statistic Functions | ||
Volatility Indicators | ||
Volume Indicators |
Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis. You can also try the Analyst Advice module to analyst recommendations and target price estimates broken down by several categories.
Other Consideration for investing in Talaris Stock
If you are still planning to invest in Talaris Therapeutics check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Talaris Therapeutics' history and understand the potential risks before investing.
Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
FinTech Suite Use AI to screen and filter profitable investment opportunities | |
Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
Stocks Directory Find actively traded stocks across global markets | |
Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
Share Portfolio Track or share privately all of your investments from the convenience of any device | |
Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets |